Company Analysis

Opus Genetics, Inc. (IRD)

Nasdaq: IRD · Pharmaceutical Preparations · Durham, NC · filing with the SEC since 2003
Grade4.4
◀ Past 4.3● Present 2.3▶ Future 6.4
1 est.

Who runs Opus Genetics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Magrath George
Chief Executive Officer. First filing Nov 2023, latest Nov 5, 2026, 9 filings in all.
Officers reporting now
7
of 15 people with a filing in the last fifteen months
Directors reporting now
8
33 people on the record since 2006
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Magrath GeorgeChief Executive OfficerNov 2023Nov 5, 20265 · $300,000
Yerxa Benjamin RPresidentOct 2024Oct 27, 20264 · $200,000
Gagnon Robert E.Chief Financial OfficerSep 2025Oct 27, 20264 · $200,000
Schachle Joseph KChief Operating OfficerNov 2023Oct 27, 20264 · $100,000
Jayagopal AshwathChief Scientific & Dev. Ofc.Feb 2024Apr 27, 20262 · $100,000
Zaremba Rabourn AmyHead of Fin. Quality AssuranceNov 2020Apr 27, 20262 · $0.00
Rodgers Richard JInterim CEO and PresidentDec 2014Apr 22, 2026none
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Foundation Fighting Blindness Retinal Degeneration FunddirectorOct 2024Oct 2, 20263 · $18.8M
Foundation Fighting Blindness, Inc.directorOct 2024Oct 2, 2026none
Gallagher CamdirectorNov 2020Sep 8, 2026none
Ainsworth SeandirectorNov 2020Apr 22, 2026none
Bennett JeandirectorOct 2024Apr 22, 2026none
Benton SusandirectorNov 2020Apr 22, 2026none
Graves Adrienne LdirectorOct 2024Apr 22, 2026none
Manuso James S JdirectorNov 2020Apr 22, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton IRD · research, not advice